Annual Accounts Receivable
N/A
31 December 2023
Summary:
TherapeuticsMD annual accounts receivable is not available.TXMD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
TherapeuticsMD quarterly accounts receivable is not available.TXMD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
TXMD Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
TherapeuticsMD Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $32.16 M(-29.8%) |
| June 2022 | - | $45.80 M(+29.3%) |
| Mar 2022 | - | $35.41 M(-5.3%) |
| Sept 2021 | - | $37.40 M(+11.7%) |
| June 2021 | - | $33.48 M(-0.7%) |
| Mar 2021 | - | $33.72 M(+4.1%) |
| Dec 2020 | $32.38 M(+32.7%) | $32.38 M(+34.6%) |
| Sept 2020 | - | $24.06 M(+31.5%) |
| June 2020 | - | $18.29 M(-11.5%) |
| Mar 2020 | - | $20.66 M(-15.3%) |
| Dec 2019 | $24.40 M(+120.5%) | $24.40 M(+59.2%) |
| Sept 2019 | - | $15.32 M(-16.6%) |
| June 2019 | - | $18.38 M(+23.0%) |
| Mar 2019 | - | $14.94 M(+35.1%) |
| Dec 2018 | $11.06 M(+155.6%) | $11.06 M(-13.6%) |
| Sept 2018 | - | $12.80 M(+127.6%) |
| June 2018 | - | $5.63 M(+10.4%) |
| Mar 2018 | - | $5.10 M(+17.7%) |
| Dec 2017 | $4.33 M(-3.8%) | $4.33 M(-1.5%) |
| Sept 2017 | - | $4.39 M(+29.3%) |
| June 2017 | - | $3.40 M(-13.4%) |
| Mar 2017 | - | $3.92 M(-12.9%) |
| Dec 2016 | $4.50 M(+47.6%) | $4.50 M(-10.6%) |
| Sept 2016 | - | $5.03 M(+12.4%) |
| June 2016 | - | $4.48 M(-11.6%) |
| Mar 2016 | - | $5.06 M(+66.0%) |
| Dec 2015 | $3.05 M(+41.6%) | $3.05 M(-16.8%) |
| Sept 2015 | - | $3.67 M(+10.7%) |
| June 2015 | - | $3.31 M(+25.3%) |
| Mar 2015 | - | $2.64 M(+22.7%) |
| Dec 2014 | $2.15 M(+27.4%) | $2.15 M(+0.3%) |
| Sept 2014 | - | $2.15 M(-0.7%) |
| June 2014 | - | $2.16 M(-7.5%) |
| Mar 2014 | - | $2.34 M(+38.4%) |
| Dec 2013 | $1.69 M(+136.7%) | $1.69 M(-5.7%) |
| Sept 2013 | - | $1.79 M(+87.3%) |
| June 2013 | - | $957.80 K(+58.9%) |
| Mar 2013 | - | $602.80 K(-15.6%) |
| Dec 2012 | $714.40 K(+2575.7%) | $714.40 K(+164.3%) |
| Sept 2012 | - | $270.30 K(-33.7%) |
| June 2012 | - | $407.90 K(+263.9%) |
| Mar 2012 | - | $112.10 K(+319.9%) |
| Dec 2011 | $26.70 K | $26.70 K(+1171.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $2100.00(-82.2%) |
| Dec 2010 | $11.80 K(+11.3%) | $11.80 K(+187.8%) |
| Sept 2010 | - | $4100.00(-54.9%) |
| June 2010 | - | $9100.00(-40.5%) |
| Mar 2010 | - | $15.30 K(+44.3%) |
| Dec 2009 | $10.60 K(>+9900.0%) | $10.60 K(>+9900.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2008 | - | $68.20 K(-21.3%) |
| Dec 2007 | $86.70 K(-30.6%) | $86.70 K(-30.1%) |
| Sept 2007 | - | $124.10 K(+4.1%) |
| June 2007 | - | $119.20 K(-13.2%) |
| Mar 2007 | - | $137.40 K(+10.0%) |
| Dec 2006 | $124.90 K(-20.9%) | $124.90 K(-5.3%) |
| Sept 2006 | - | $131.90 K(-4.9%) |
| June 2006 | - | $138.70 K(+5.0%) |
| Mar 2006 | - | $132.10 K(-16.4%) |
| Dec 2005 | $158.00 K(+44.0%) | $158.00 K(+2.2%) |
| Sept 2005 | - | $154.60 K(+37.8%) |
| June 2005 | - | $112.20 K(+13.3%) |
| Mar 2005 | - | $99.00 K(-9.8%) |
| Dec 2004 | $109.70 K(+36.3%) | $109.70 K(+3.0%) |
| Sept 2004 | - | $106.50 K(+22.4%) |
| June 2004 | - | $87.00 K(-17.9%) |
| Mar 2004 | - | $106.00 K(+31.7%) |
| Dec 2003 | $80.50 K(+64.6%) | $80.50 K(+18.2%) |
| Sept 2003 | - | $68.10 K(-8.1%) |
| June 2003 | - | $74.10 K(+11.6%) |
| Mar 2003 | - | $66.40 K(+35.8%) |
| Dec 2002 | $48.90 K(-0.6%) | $48.90 K(+4.3%) |
| Sept 2002 | - | $46.90 K(+35.2%) |
| June 2002 | - | $34.70 K(-2.8%) |
| Mar 2002 | - | $35.70 K(-27.4%) |
| Dec 2001 | $49.20 K(-46.3%) | $49.20 K(-8.4%) |
| Sept 2001 | - | $53.70 K(-19.1%) |
| June 2001 | - | $66.40 K(-27.6%) |
| Dec 2000 | $91.70 K(>+9900.0%) | $91.70 K(>+9900.0%) |
| Sept 2000 | - | $0.00(-100.0%) |
| Mar 2000 | - | $50.50 K(>+9900.0%) |
| Dec 1999 | $0.00(0.0%) | $0.00 |
| Dec 1998 | $0.00(0.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00(-100.0%) | - |
| Dec 1995 | $32.70 K(>+9900.0%) | - |
| Dec 1994 | $0.00 | - |
FAQ
- What is the all time high annual accounts receivable for TherapeuticsMD?
- What is the all time high quarterly accounts receivable for TherapeuticsMD?
What is the all time high annual accounts receivable for TherapeuticsMD?
TherapeuticsMD all-time high annual accounts receivable is $32.38 M
What is the all time high quarterly accounts receivable for TherapeuticsMD?
TherapeuticsMD all-time high quarterly accounts receivable is $45.80 M